| Open Document File Size: 3,00 MBShare Result on Facebook
City Reference / Bristol / / Company Cohort I / / IndustryTerm HBV treatment / treatment / experienced / treatment-naïve / e-antigen / / MedicalCondition virus infection / disease / Decompensated liver disease / HBV / infection / liver disease / chronic hepatitis B / HBeAg-positive chronic HBV infection / compensated liver disease / hepatitis B / / Organization OND Division Division of Antiviral Products Applicant Bristol-Myers Squibb Formulation Tablet / Division of Antiviral Products / office of Clinical Pharmacology / / Person Jeffry Florian / Su-Young Choi / Shirley Seo / Yaning Wang / / Position Ph.D Team Leader Pharmacometrics Team Leader / / Product Lamivudine / Squibb Formulation Tablet / Baraclude / / Technology pharmacokinetics / /
SocialTag |
N21-797S018 Entecavir Clinpharm BPCA